Addressing the room for improvement in management of acute promyelocytic leukemia.

Jan Maxwell NørgaardLone S FriisJørgen S KristensenMarianne T SeverinsenIngolf MølleClaus W MarcherPeter MøllerClaudia SchoellkopfOve J NielsenBirgitte S PreissMette K AndersenEigil KjeldsenBruno C MedeirosLene S G Østgårdnull null

Published in: European journal of haematology (2019)

The very low EDR for on-trial patients is not observed in the general cohort of APL patients. Diagnostic awareness emerges as the greatest clinical challenge in management of APL.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
randomized controlled trial
clinical trial
liver failure
patient reported outcomes
study protocol
acute respiratory distress syndrome